Navigation Links
Dow AgroSciences' Success Presented to Wall Street
Date:2/12/2008

Company Outlines Ambitious Growth Plans, Technology Leadership

INDIANAPOLIS, Feb. 12 /PRNewswire-FirstCall/ -- The growing technology share of Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), was the focus of a presentation made to investors earlier today by Jerome Peribere, president and CEO of Dow AgroSciences. Peribere was speaking at the Goldman Sachs Agricultural Chemicals Conference in New York City, where he reinforced Dow AgroSciences' technology-based strategy of growing its agricultural chemicals business while developing new biotechnology products and platforms.

"We believe the company with the best technology will ultimately generate the most value," said Peribere. "We are building our capabilities to do exactly that and provide our customers with revolutionary solutions."

He cited numerous examples of the Company's innovation -- from both the chemical and biological sides of the portfolio -- and highlighted the progress of the seeds business during 2007, including growth in the Americas for its corn, cotton, sunflower, and canola product portfolios.

A key move in 2007 was the Company's announcement of its SmartStax(TM) agreement with Monsanto, creating the industry's first eight-gene stack of traits in corn. As a result of this scientific breakthrough, Peribere expects Dow's HERCULEX(TM) insect protection technology to be on approximately 40 percent of U.S. corn acres in the SmartStax launch year of 2010 and on about 60 percent of acres by 2012. This technology package will be further enhanced when Dow AgroSciences launches its Dow Herbicide Tolerance technology in 2012 for corn, and in 2013 for cotton and soybeans.

Peribere concluded that growth for Dow AgroSciences will continue as the Company develops technology leadership, builds a billion-dollar corn business and advances its ag chemical pipeline.

About Dow

With annual sales of $54 billion and 46,000 employees worldwide, Dow is a diversified chemical company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. The Company delivers a broad range of products and services to customers in around 160 countries, connecting chemistry and innovation with the principles of sustainability to help provide everything from fresh water, food and pharmaceuticals to paints, packaging and personal care products. References to "Dow" or the "Company" mean The Dow Chemical Company and its consolidated subsidiaries unless otherwise expressly noted. More information about Dow can be found at http://www.dow.com

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $3.8 billion. Learn more at http://www.dowagro.com.

(TM)Trademark of Dow AgroSciences LLC

SmartStax(TM) is a trademark of Monsanto Company


'/>"/>
SOURCE The Dow Chemical Company
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
2. ThromboGenics Announces Successful Completion of Technology Transfer to Bharat Biotech for Production of Novel Thrombolytic Agent
3. ThromboGenics and BioInvent Announce Successful Completion of Phase I Clinical Trial of the Anticoagulant TB-402
4. EpiStem Successfully Complete First Year of Mucositis Tests for NIH Biodefence Programme
5. Life on Mars pregnancy test successfully launched
6. Of mice and men: new male contraceptives successful in rodents and humans
7. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
8. AMDL to Present its China Success Story at Rodman & Renshaw 9th Annual Healthcare Conference
9. Clinical Study Findings Show Safety and Procedure Success for TopSpin IntraVascular MRI Catheter for the Coronary Arteries
10. ARIUS announces cancer stem cell antibody program successfully completes first toxicology study
11. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Laurel, NJ (PRWEB) , ... December 06, 2016 ... ... white paper on December 1, 2016 asking the Federal Drug Administration (FDA) to ... the study of OA, OARSI is concerned about the growing population of OA ...
(Date:12/6/2016)... Colorado (PRWEB) , ... December 06, 2016 , ... ... dynamic aqueous plasma technology platforms, announced today that the company has engaged in ... Research and Development Agreement (MRDA) with the CSU Office of the Vice President ...
(Date:12/6/2016)... PHOENIX and SAN DIEGO ... (OTCQB:CELZ) announced the appointment of Santosh Kesari , ... Board. Dr. Kesari will leverage his experience in neurology and ... its adult stem cell for treatment of stroke. The AmnioStem ... amniotic fluid, which has previously shown therapeutic activity in ...
(Date:12/6/2016)... MELBOURNE, Australia , Dec. 6, 2016  The ... Health Informatics Society of Australia (HISA) today announced ... technology startup exchange program between Australia ... city in the world. HISA and ... are initiating a program to create a global health ...
Breaking Biology Technology:
(Date:11/19/2016)... Securus Technologies, a leading provider of civil ... corrections and monitoring, announced today that it has offered ... an independent technology judge determine who has the largest ... telephone calling platform, and the best customer service. ... of what we do – which clearly is not ...
(Date:11/17/2016)... 2016  AIC announces that it has just released a new white paper authored ... scale-out plus high speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
Breaking Biology News(10 mins):